Thermo Fisher opens clinical supply facility in Singapore
December 1, 2015
An overall building monitoring system is a key feature of Thermo Fisher Scientific’s just opened clinical supply facility in Singapore. The Massachusetts-based company said the opening was part of its plan to address the growing global demand for clinical services.
Having established its first clinical services facility in Singapore in 2001, the move to this newly built facility aims to meet the growing demand for clinical supply services in the region. The site will provide both regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies − from GMP (good manufacturing practices) storage, local labelling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management.
Located in Toh Guan Road, Jurong East − the hub for Singapore’s biomedical and pharmaceutical companies − the facility is nearly 6500 square metres, more than 60 per cent larger than the previous site and double the cold chain capacity.
The clinical services facility is also well equipped with improved technologies and operational tools to serve a growing need for clinical supplies and trials in the region. This includes a larger storage system for its clinical supplies, a climatic control energy consumption system that reduces the facility’s carbon footprint, and an overall building monitoring system that provides staff with timely updates on the facility’s conditions.
“Asia Pacific continues to be our fastest-growing market and a central contributor to our growth,” said Leon Wyszkowski, Thermo Fisher’s vice president of clinical services for North America and facility network. “For nearly 15 years, Singapore has been the central hub for our Asia-Pacific operations, due to its strategic location. With the opening of our larger and well-equipped facility, we aim to continue to build on our Singapore facility further and on the expertise of our local team, to strengthen our regional and global presence in the clinical supplies industry.”
Thermo Fisher Scientific has revenues of US$17bn and approximately 50,000 employees in 50 countries.